Maria Koehler - 11 Dec 2023 Form 4 Insider Report for Repare Therapeutics Inc. (RPTX)

Role
EVP, Chief Medical Officer
Signature
/s/ Steve Forte, Attorney-in-Fact
Issuer symbol
RPTX
Transactions as of
11 Dec 2023
Net transactions value
+$98,755
Form type
4
Filing time
12 Dec 2023, 16:19:06 UTC
Previous filing
13 Jun 2023
Next filing
04 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPTX Common Shares Options Exercise $41,632 +20,190 +11% $2.06 196,153 11 Dec 2023 Direct
transaction RPTX Common Shares Options Exercise $57,123 +23,556 +12% $2.42 219,709 11 Dec 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RPTX Employee Stock Option (right to buy) Options Exercise $0 -20,190 -45% $0.000000 24,229 11 Dec 2023 Common Shares 20,190 $2.06 Direct F1
transaction RPTX Employee Stock Option (right to buy) Options Exercise $0 -23,556 -21% $0.000000 87,691 11 Dec 2023 Common Shares 23,556 $2.42 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested and exercisable.
F2 Twenty-five percent (25%) of the shares subject to the option vested on December 16, 2020, and one thirty-ninth (1/39th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.